Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laryngeal Neoplasms | 5 | 2022 | 533 | 0.590 |
Why?
|
| Head and Neck Neoplasms | 12 | 2022 | 4138 | 0.540 |
Why?
|
| Tongue Neoplasms | 2 | 2010 | 252 | 0.540 |
Why?
|
| Quality Indicators, Health Care | 4 | 2015 | 364 | 0.510 |
Why?
|
| Laryngectomy | 5 | 2022 | 243 | 0.490 |
Why?
|
| Oropharyngeal Neoplasms | 4 | 2020 | 1159 | 0.330 |
Why?
|
| Guideline Adherence | 2 | 2010 | 649 | 0.330 |
Why?
|
| Otolaryngology | 2 | 2020 | 141 | 0.310 |
Why?
|
| Carcinoma, Merkel Cell | 2 | 2006 | 172 | 0.270 |
Why?
|
| Lip Neoplasms | 2 | 2006 | 20 | 0.270 |
Why?
|
| Pharyngeal Diseases | 2 | 2022 | 51 | 0.240 |
Why?
|
| Mandibular Neoplasms | 2 | 2019 | 77 | 0.240 |
Why?
|
| Cutaneous Fistula | 2 | 2022 | 45 | 0.240 |
Why?
|
| Cancer Care Facilities | 3 | 2022 | 908 | 0.240 |
Why?
|
| Mandibular Osteotomy | 2 | 2022 | 39 | 0.210 |
Why?
|
| Thyroid Neoplasms | 2 | 2016 | 1884 | 0.210 |
Why?
|
| Neck Dissection | 2 | 2014 | 294 | 0.190 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2016 | 263 | 0.190 |
Why?
|
| Osteoradionecrosis | 1 | 2022 | 128 | 0.180 |
Why?
|
| Oncology Service, Hospital | 1 | 2020 | 49 | 0.180 |
Why?
|
| Quality Improvement | 3 | 2018 | 918 | 0.170 |
Why?
|
| Academic Medical Centers | 2 | 2016 | 690 | 0.170 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2019 | 10365 | 0.170 |
Why?
|
| Masseter Muscle | 1 | 1999 | 9 | 0.170 |
Why?
|
| Temporomandibular Joint | 1 | 1999 | 22 | 0.170 |
Why?
|
| Neoplasms, Connective Tissue | 1 | 2019 | 20 | 0.160 |
Why?
|
| Fellowships and Scholarships | 2 | 2020 | 409 | 0.160 |
Why?
|
| Hypophosphatemia | 1 | 2019 | 27 | 0.160 |
Why?
|
| Lymphocyte Count | 1 | 2020 | 485 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2019 | 5603 | 0.150 |
Why?
|
| Hemangioma | 1 | 1999 | 161 | 0.150 |
Why?
|
| Patient Care Bundles | 1 | 2017 | 30 | 0.150 |
Why?
|
| Vocal Cords | 1 | 2018 | 105 | 0.140 |
Why?
|
| Gastrostomy | 1 | 2018 | 194 | 0.140 |
Why?
|
| Patient Readmission | 3 | 2016 | 592 | 0.140 |
Why?
|
| Speech, Alaryngeal | 1 | 2016 | 24 | 0.140 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2016 | 142 | 0.130 |
Why?
|
| Punctures | 1 | 2016 | 105 | 0.130 |
Why?
|
| Enteral Nutrition | 1 | 2018 | 345 | 0.130 |
Why?
|
| Middle Aged | 22 | 2022 | 90460 | 0.130 |
Why?
|
| Laminectomy | 1 | 2015 | 52 | 0.130 |
Why?
|
| Cervical Cord | 1 | 2015 | 18 | 0.130 |
Why?
|
| Population Surveillance | 1 | 2019 | 650 | 0.130 |
Why?
|
| Radiotherapy, Adjuvant | 5 | 2016 | 2270 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2020 | 1327 | 0.120 |
Why?
|
| Feedback, Psychological | 1 | 2015 | 20 | 0.120 |
Why?
|
| Iatrogenic Disease | 1 | 2016 | 197 | 0.120 |
Why?
|
| Neoadjuvant Therapy | 3 | 2020 | 5213 | 0.120 |
Why?
|
| Vocal Cord Paralysis | 1 | 2016 | 94 | 0.120 |
Why?
|
| Length of Stay | 3 | 2016 | 2015 | 0.120 |
Why?
|
| Weight Loss | 1 | 2018 | 639 | 0.120 |
Why?
|
| Curriculum | 1 | 2020 | 910 | 0.120 |
Why?
|
| Education, Medical, Graduate | 2 | 2020 | 700 | 0.110 |
Why?
|
| Medical Audit | 1 | 2015 | 198 | 0.110 |
Why?
|
| Specialties, Surgical | 1 | 2016 | 134 | 0.110 |
Why?
|
| Male | 24 | 2022 | 129089 | 0.110 |
Why?
|
| Ipilimumab | 1 | 2018 | 759 | 0.110 |
Why?
|
| Melanoma | 2 | 2018 | 5592 | 0.110 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 31066 | 0.110 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 864 | 0.110 |
Why?
|
| Humans | 33 | 2022 | 272091 | 0.100 |
Why?
|
| Health Care Costs | 1 | 2017 | 700 | 0.100 |
Why?
|
| Alphapapillomavirus | 1 | 2014 | 174 | 0.100 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 633 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 1659 | 0.100 |
Why?
|
| Meningioma | 1 | 2015 | 307 | 0.100 |
Why?
|
| Chemoradiotherapy | 2 | 2018 | 2029 | 0.100 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 709 | 0.100 |
Why?
|
| Adult | 17 | 2019 | 81933 | 0.100 |
Why?
|
| Robotic Surgical Procedures | 1 | 2018 | 529 | 0.100 |
Why?
|
| Tumor Burden | 1 | 2017 | 2035 | 0.090 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 5935 | 0.090 |
Why?
|
| Sleep Wake Disorders | 1 | 2014 | 372 | 0.090 |
Why?
|
| Meningeal Neoplasms | 1 | 2015 | 473 | 0.090 |
Why?
|
| Aged | 15 | 2022 | 73517 | 0.090 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2009 | 23 | 0.090 |
Why?
|
| Retrospective Studies | 12 | 2022 | 39831 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 4071 | 0.090 |
Why?
|
| Mouth Mucosa | 2 | 2009 | 225 | 0.080 |
Why?
|
| Female | 19 | 2022 | 149288 | 0.080 |
Why?
|
| Surgical Procedures, Operative | 2 | 2010 | 358 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2020 | 1441 | 0.080 |
Why?
|
| Cohort Studies | 5 | 2022 | 9500 | 0.080 |
Why?
|
| Teratocarcinoma | 1 | 2008 | 24 | 0.080 |
Why?
|
| Neoplasm Staging | 5 | 2018 | 13993 | 0.080 |
Why?
|
| Surgeons | 1 | 2015 | 487 | 0.080 |
Why?
|
| Treatment Outcome | 8 | 2020 | 33909 | 0.070 |
Why?
|
| Combined Modality Therapy | 6 | 2017 | 9046 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 16612 | 0.070 |
Why?
|
| Risk Factors | 5 | 2020 | 18051 | 0.070 |
Why?
|
| Survival Analysis | 4 | 2019 | 9326 | 0.070 |
Why?
|
| Collagen | 1 | 2009 | 739 | 0.070 |
Why?
|
| Keratin-20 | 1 | 2006 | 45 | 0.070 |
Why?
|
| Surgical Wound Infection | 3 | 2016 | 481 | 0.070 |
Why?
|
| Synaptophysin | 1 | 2006 | 83 | 0.070 |
Why?
|
| Chromogranin A | 1 | 2006 | 66 | 0.070 |
Why?
|
| Chromogranins | 1 | 2006 | 88 | 0.070 |
Why?
|
| Thyroid Gland | 1 | 2008 | 369 | 0.070 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2006 | 90 | 0.060 |
Why?
|
| Mandible | 2 | 2022 | 191 | 0.060 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 1014 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 613 | 0.060 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2008 | 285 | 0.060 |
Why?
|
| Postoperative Complications | 2 | 2020 | 5693 | 0.060 |
Why?
|
| Keratins | 1 | 2006 | 352 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2020 | 7828 | 0.060 |
Why?
|
| Polysomnography | 2 | 2016 | 178 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2006 | 835 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2014 | 3080 | 0.050 |
Why?
|
| Risk Assessment | 3 | 2020 | 6885 | 0.050 |
Why?
|
| Texas | 3 | 2020 | 6440 | 0.050 |
Why?
|
| United States | 4 | 2020 | 16066 | 0.050 |
Why?
|
| Incidence | 3 | 2018 | 5864 | 0.050 |
Why?
|
| Margins of Excision | 1 | 2022 | 314 | 0.040 |
Why?
|
| Disease-Free Survival | 3 | 2018 | 10259 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 4352 | 0.040 |
Why?
|
| Occupational Health | 1 | 2020 | 93 | 0.040 |
Why?
|
| Radiotherapy | 2 | 2017 | 1860 | 0.040 |
Why?
|
| Employment | 1 | 2020 | 121 | 0.040 |
Why?
|
| Drainage | 1 | 2022 | 448 | 0.040 |
Why?
|
| Jaw | 1 | 1999 | 20 | 0.040 |
Why?
|
| Osteomalacia | 1 | 2019 | 36 | 0.040 |
Why?
|
| Canada | 1 | 2020 | 441 | 0.040 |
Why?
|
| Time Factors | 3 | 2020 | 13139 | 0.040 |
Why?
|
| Adolescent | 4 | 2019 | 32730 | 0.040 |
Why?
|
| Salivary Ducts | 1 | 1999 | 55 | 0.040 |
Why?
|
| Self Concept | 1 | 2020 | 200 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2015 | 7792 | 0.040 |
Why?
|
| Career Choice | 1 | 2020 | 209 | 0.040 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2019 | 84 | 0.040 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 175 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2020 | 485 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 4900 | 0.040 |
Why?
|
| Fibula | 1 | 2019 | 152 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 15279 | 0.040 |
Why?
|
| Prognosis | 3 | 2018 | 22555 | 0.040 |
Why?
|
| Hypoalbuminemia | 1 | 2016 | 44 | 0.040 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2018 | 98 | 0.040 |
Why?
|
| Speech Intelligibility | 1 | 2016 | 40 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2022 | 813 | 0.030 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 313 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2016 | 77 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2016 | 125 | 0.030 |
Why?
|
| Larynx | 1 | 2017 | 144 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2016 | 349 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 2016 | 93 | 0.030 |
Why?
|
| Hematoma | 1 | 2016 | 159 | 0.030 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2017 | 210 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2018 | 1589 | 0.030 |
Why?
|
| Blood Component Transfusion | 1 | 2015 | 89 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2015 | 220 | 0.030 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2014 | 85 | 0.030 |
Why?
|
| Biomarkers | 1 | 2006 | 5115 | 0.030 |
Why?
|
| Patient Safety | 1 | 2020 | 655 | 0.030 |
Why?
|
| Trachea | 1 | 2016 | 290 | 0.030 |
Why?
|
| Free Tissue Flaps | 1 | 2019 | 374 | 0.030 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 630 | 0.030 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2014 | 80 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 264 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 2058 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2019 | 13410 | 0.030 |
Why?
|
| Esophagus | 1 | 2016 | 564 | 0.030 |
Why?
|
| Young Adult | 3 | 2019 | 22142 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 2335 | 0.020 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 5330 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 2867 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1607 | 0.020 |
Why?
|
| Registries | 1 | 2019 | 2253 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 7958 | 0.020 |
Why?
|
| Surgical Flaps | 1 | 2016 | 882 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 1342 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2019 | 2119 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 2355 | 0.020 |
Why?
|
| Reoperation | 1 | 2015 | 1391 | 0.020 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2016 | 879 | 0.020 |
Why?
|
| Desmin | 1 | 2009 | 64 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2015 | 1317 | 0.020 |
Why?
|
| Disease Progression | 1 | 2020 | 6911 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 3395 | 0.020 |
Why?
|
| Fatigue | 1 | 2014 | 1281 | 0.020 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2008 | 57 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 2538 | 0.020 |
Why?
|
| Logistic Models | 1 | 2014 | 3469 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 557 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 4496 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2009 | 498 | 0.020 |
Why?
|
| Actins | 1 | 2009 | 617 | 0.020 |
Why?
|
| Biomarkers, Tumor | 2 | 2020 | 10750 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2009 | 698 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2014 | 3980 | 0.020 |
Why?
|
| Quality of Life | 1 | 2020 | 4755 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 2198 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 4968 | 0.020 |
Why?
|
| Survival Rate | 2 | 2010 | 12534 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 2430 | 0.010 |
Why?
|
| Child | 1 | 2010 | 30559 | 0.010 |
Why?
|